Studies and methodologies on vaginal drug permeation

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Biomedical Engineering

Background:

• The vaginal route is a viable alternative for systemic drug delivery, especially for drugs with poor oral absorption or rapid hepatic metabolism.
• Accurate prediction of drug permeation through vaginal tissue is crucial for developing effective vaginal drug formulations.
• Existing in vivo models present ethical and biological challenges, necessitating the development of reliable in vitro and ex vivo alternatives.

Purpose of the Study:

• To review and analyze various methodologies for studying vaginal drug permeation.
• To discuss the advantages and disadvantages of different in vitro, ex vivo, and in vivo models.
• To emphasize the importance of model validation and standardization for improving vaginal drug research.

Main Methods:

• Literature review of existing models for vaginal drug permeation studies.
• Comparative analysis of in vitro, ex vivo, and in vivo approaches.
• Discussion of technical complexity, cost, ethical considerations, accuracy, and reproducibility of each model.

Main Results:

• In vitro and ex vivo models offer alternatives to in vivo studies, enabling simultaneous toxicity and pathogenesis assessments.
• Each model possesses unique advantages and drawbacks influencing its applicability and validity.
• Model evaluation, validation, and standardization are essential for reliable extrapolation of results.

Conclusions:

• Standardized and validated models are critical for advancing vaginal drug research and development.
• Careful selection and evaluation of models are necessary to overcome limitations and maximize benefits.
• Improved methodologies will enhance the understanding and application of vaginal drug delivery systems.